Major clinical breast cancer study begins

Apr 04, 2007

U.S. medical researchers have found combining two drugs targeted against HER2-positive breast cancer might offer more benefit than just using one.

Dr. Edith Perez, director of the Mayo Clinic's Jacksonville, Fla., Breast Clinic., is leading a national trial with 109 participants that will look at the safety and benefit of adding lapatinib (Tykerb) to trastuzumab (Herceptin) for the treatment of early stage HER2-positive breast cancer.

The study -- the first major clinical research of its kind -- started March 16 with patient recruitment.

"Worldwide, no more than 100 patients have been tested with this combination treatment, so we are pleased that we now offer a comprehensive study in the United States to assess the possible benefit of this therapy," said Perez.

She will lead a consortium of 35 investigators who will enroll 109 participants at up to 100 different cancer treatment centers across the nation.

"We are finding that the best way to treat a cancer is to understand the biological characteristics of the cancer and then use therapies directed at those specific biological or molecular abnormalities," she added.

Information about the study is available at
clinicaltrials.mayo.edu.

Copyright 2007 by United Press International

Explore further: Global health experts call into question sub-Saharan cancer data

add to favorites email to friend print save as pdf

Related Stories

Huge spring tides draw crowds to French Atlantic coast

17 hours ago

France kicked off nearly a month of exceptionally large spring tides Saturday, as tourists flocked to coastal areas to witness spectacularly high water levels ahead of the so-called "tide of the century" ...

Water in Oregon pipeline is tapped for electricity

19 hours ago

Lucid Energy has developed a renewable energy system that makes use of water moving through pipelines. The company's LucidPipe Power System converts pressure in water pipelines into electricity. They have ...

Arctic oil drillers face tighter US rules to stop spills

21 hours ago

Royal Dutch Shell Plc and any oil drilling company that prospects in the Arctic Ocean must boost safety practices to prevent spills in the frigid and often hostile waters or mitigate the impact, U.S. regulators proposed Friday.

Recommended for you

Cancer drug first tested in pet dogs begins human trials

11 hours ago

A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.